Plasminogen activators and plasmin — Drug Target

All drugs that target Plasminogen activators and plasmin — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antifibrinolytic

Phase 2 pipeline (1)

• Antifibrinolytic treatment · Bayer · Antifibrinolytic · Oncology
  Antifibrinolytic agents inhibit plasminogen activators and plasmin.